It is possible that the higher level of ELA2 transcript detected in some of the CML samples is contributed by a small subset of the CD34+ cells in which case an associated hypomethylation of the ELA2 gene would have been masked by the situation in the bulk of the cells. The gene discussed is CD34; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.